-
Current indications for cardiac-resynchronization therapy (CRT) require that patients have New York Heart Association (NYHA) Class III or Class IV heart-failure symptoms.
-
Dabigatran etexilate is an oral compound that is converted after absorption by a serum esterase to dabigatran, a direct competitive inhibitor of thrombin.
-
In this issue: Efficacy of once-daily insulin, aldo-sterone use in heart failure, erectile dysfunction Clinical Practice Guidelines, and FDA Actions.
-
Until recently, the literature has offered little direction on how to manage patients who have short cervices in the second trimester.
-
A 2009 influenza a (h1n1) vaccine was evaluated in a large randomized placebo controlled study in China. The immunization schedule consisted of two doses administered 21 days apart.
-
-
It is not a great mystery that primary ovarian cancer, when presenting with metastatic intra-abdominal and/or extra-abdominal disease, represents a formidable therapeutic challenge, as these women are usually highly symptomatic, frequently of poor nutrition, and in need of aggressive dual modality therapy: surgery and chemotherapy.
-
The Guttmacher Institute, in collaboration with the World Health Organization, recently published an updated account of abortion rates worldwide.
-
Encouraging news comes from the HIV vaccine research front, where an investigational vaccine regimen tested in a Thailand clinical trial has been shown to be well tolerated and to have a modest effect in preventing HIV infection.
-
As the United States gears up to combat the H1N1 flu (also known as swine flu), be sure your practice includes the latest Centers for Disease Control and Prevention (CDC) recommendations for care of pregnant women.